Leidos Names Dr. Donald Kosiak Chief Medical Officer

News provided by

Feb 03, 2016, 04:15 ET

Leidos logo.

RESTON, Va., Feb. 3, 2016 /PRNewswire/ -- Leidos (NYSE: LDOS), a health, national security, and engineering solutions company, today announced the appointment of Donald Kosiak Jr., MD as Chief Medical Officer, effective February 8. In his new role, Dr. Kosiak will be responsible for providing clinical subject matter expertise and perspective, knowledge, experience, leadership and direction to ensure collaboration and alignment to business strategy across the Health Solution Group and entire Leidos organization. He will also provide clinical domain support in the pursuit of new market and business development activities, strategic business initiatives, and new product/solution development.

Prior to joining Leidos, Dr. Kosiak served as the Vice President for Medical Development and Avera eCARE Executive Medical Director for Avera Health, a 32-hospital integrated medical system based in Sioux Falls, South Dakota. In this role, he served as the chief medical officer of one of the top telemedicine programs in the United States. In addition, he has served as Regional Medical Information Officer and as the elected Chief of Staff of the Avera McKennan Hospital & University Health Center, a 545-bed tertiary medical center located in Sioux Falls, South Dakota. Dr. Kosiak has held leadership roles for several national and international projects including work for the North Atlantic Treaty Organization Science for Peace and Security Program, providing medical leadership for the development of a multinational telemedicine response system for use in humanitarian crisis situations and global disaster response. Dr. Kosiak continues to serve in the Army National Guard as an emergency physician. He currently holds the position of State Surgeon for the South Dakota Army National Guard. He is a decorated officer having served three tours of duty in support of Operation Iraqi and Enduring Freedom.

"Dr. Kosiak brings strong leadership and significant clinical expertise," said Leidos Health and Engineering Sector President, Jon Scholl. "Don is a perfect fit at Leidos, having medical, technical and military experience. We are delighted to have him on the Leidos team, which is well known for delivering solutions that improve health outcomes to the citizens of our nation, both military and civilian."

Dr. Kosiak attended medical school at the University of North Dakota. He completed his emergency medicine residency at the Mayo Clinic in Rochester, Minnesota. In 2010, he completed his Masters of Business Administration from the University of Mary. He holds certification from the American Board of Emergency Medicine and the Certifying Commission in Medical Management.

About Leidos
Leidos is a science and technology solutions leader working to address some of the world's toughest challenges in national security, health and engineering. The Company's 19,000 employees support vital missions for government and the commercial sector, develop innovative solutions to drive better outcomes and defend our digital and physical infrastructure from 'new world' threats. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $5.06 billion for its fiscal year ended January 30, 2015. For more information, visit www.Leidos.com.

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 30, 2015, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.